Colorectal cancer has become the deadliest cancer among Americans under 50, with diagnoses rising since the mid-1990s even as rates among older adults decline. The trend is also being reported internationally, with people born in the 1990s facing at least four times the risk of developing colorectal cancer compared with those born in the 1960s in countries including Australia, Canada and England. Although screening guidelines in the US were lowered to age 45 in 2021, researchers say the reasons behind the increase remain unclear. Delayed diagnosis may contribute, but experts suspect additional biological and environmental factors.
Several research directions are emerging. One international study identified two DNA mutational signatures found more than three times as often in patients under 40 than in those aged 70 and older. These patterns may be linked to colibactin, a toxin produced by certain gut bacteria, including pks-positive E. coli, although its role in early-onset cancer remains unproven. Researchers are also investigating early-life exposures, diet, physical activity, plastics, environmental chemicals and the gut microbiome. Separately, a small tissue study found greater stiffness and altered collagen organization in both cancerous and noncancerous colon tissue from younger patients, potentially reflecting chronic inflammation and fibrosis.
Younger patients may also have distinct disease characteristics. Research has identified higher rates of aggressive signet ring cell carcinoma and a greater tendency for tumors to occur in the left colon and rectum. Scientists are studying these differences, but the findings are not yet sufficient to guide new prevention or treatment strategies. Researchers emphasize the need for more evidence before recommending screening below age 45 for people without established risk factors. More accessible stool and blood-based tests may eventually help identify people who need diagnostic follow-up.

